32.2
Novartis AG Sponsored ADR
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
31.9
FY23:
34.2
FY24:
38.9
FY25:
43.0
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.1
FY22:
7.95
FY23:
9.77
FY24:
14.5
FY25:
17.6
(positive)
Change from FY21 to FY25
billions USD
FY21:
24.5
FY22:
7.18
FY23:
9.12
FY24:
13.6
FY25:
16.4
(positive)
Change from FY21 to FY25
billions USD
FY21:
24.0
FY22:
6.96
FY23:
14.9
FY24:
11.9
FY25:
14.0
All amounts in billions USD